Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
Study NCT ID:
NCT05152212
Status:
COMPLETED
Last Update Posted:
2024-04-22
First Post:
2021-11-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of LVGN7409 (CD40 Agonist Antibody) in Locally Advanced, Metastatic or Recurrent/Refractory Malignancy
Sponsor:
Lyvgen Biopharma Holdings Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-09
First Submit QC Date:
None
Study First Post Date:
2021-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-18
Last Update Post Date:
2024-04-22
Last Update Post Date Type:
ACTUAL